These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 710319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Loeb HS, Bredakis J, Gunner RM.
    Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
    Leier CV, Heban PT, Huss P, Bush CA, Lewis RP.
    Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

  • 14. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O, Crea F, Pesola A, Distante A, Chierchia S, Moscarelli E, L'Abbate A, Maseri A.
    G Ital Cardiol; 1980 Oct; 10(9):1141-7. PubMed ID: 7193152
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dopamine and dobutamine as treatment of circulatory shock initially non-cardiogenic: a clinical study (author's transl)].
    Constantin B, Racle JP, Chausset R, Ferrier C, Laplaud D.
    Therapie; 1980 Oct; 35(5):619-26. PubMed ID: 7209859
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP, Tweddel AC, Hutton I.
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [Abstract] [Full Text] [Related]

  • 19. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
    Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters GT, Stinson EB, Ingels NB, Mitchell RS, Miller DC.
    Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
    [Abstract] [Full Text] [Related]

  • 20. Comparison of digoxin and dobutamine in patients with severe dilatative cardiomyopathy.
    Bonelli J, Jancuska M.
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):120-5. PubMed ID: 2722306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.